Wei Tang
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 9
- Cancer, Hypoxia, and Metabolism 7
- Hepatology top 5%
- Oncology top 5%
- Cancer-related Molecular Pathways 4
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 13
- Metabolism, Diabetes, and Cancer 5
- Immunology top 10%
- interferon and immune responses 5
- Immune Cell Function and Interaction 4
-
- Prostate Cancer Treatment and Research 12
- Co-authors
- Colin SumnersMohan K. RaizadaStefan AmbsBlanka ŽeleznáWilliam R. FolkTiffany H. DorseyLudmila Prokunina‐OlssonJacques Piette
- Cited by
- Cancer ResearchHepatologyOncology
- Journals
- Cancer Epidemiology Biomarkers & Prevention (3 papers)Cancer Research (3 papers)Genome biology (3 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Wei Tang
84 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 687
- Hepatology 272
- Oncology 691
- Molecular Biology 1.5k
- Immunology 340
Countries citing papers authored by Wei Tang
This map shows the geographic impact of Wei Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Tang more than expected).
Fields of papers citing papers by Wei Tang
This network shows the impact of papers produced by Wei Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Tang. The network helps show where Wei Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 27 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 45 | |
| 10 | 2019 | 44 | |
| 11 | 2018 | 38 | |
| 12 | 2018 | 20 | |
| 13 | 2018 | 118 | |
| 14 | 2017 | 41 | |
| 15 | 2016 | 225 | |
| 16 | 2015 | 14 | |
| 17 | 2015 | 28 | |
| 18 | 2013 | 76 | |
| 19 | 1992 | 2 | |
| 20 | 1987 | 48 |
About Wei Tang
Wei Tang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 88 papers that have together received 2.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (13 papers), Prostate Cancer Treatment and Research (12 papers), Cancer-related molecular mechanisms research (9 papers), Cancer, Hypoxia, and Metabolism (7 papers), interferon and immune responses (5 papers), Metabolism, Diabetes, and Cancer (5 papers), Cancer-related Molecular Pathways (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Cancer Research (687 citations), Hepatology (272 citations) and Oncology (691 citations). Wei Tang has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Colin Sumners, Mohan K. Raizada, Stefan Ambs, Blanka Železná, William R. Folk, Tiffany H. Dorsey, Ludmila Prokunina‐Olsson, Jacques Piette, M. Elena Martı́n and Moshé Yaniv. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Cancer Research, Genome biology, Molecular and Cellular Biology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.